Clusterin Immunoreactivity as a Predictive Factor for Progression of Non-Muscle-Invasive Bladder Carcinoma

Publisher： Karger

E-ISSN： 1423-0399|86|1|31-35

ISSN： 0042-1138

Source： Urologia Internationalis, Vol.86, Iss.1, 2010-11, pp. : 31-35

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Diagnosis and treatment of non‐muscle‐invasive bladder cancer

By  

TRENDS IN UROLOGY AND MEN'S HEALTH, Vol. 6, Iss. 2, 2015-03 ,pp. : 23-27

John Wiley & Sons Inc

Access to resources Recommend Favorite

Recurrence and Progression in Non-Muscle-Invasive Bladder Cancer Using EORTC Risk Tables

By  

Urologia Internationalis, Vol. 89, Iss. 1, 2012-06 ,pp. : 61-66

Karger

Access to resources Recommend Favorite

Tumor Suppressor in Lung Cancer-1 Is a Prognostic Predictor for the Recurrence and Progression of Non-Muscle-Invasive Bladder Cancer

By  

Urologia Internationalis, Vol. 96, Iss. 2, 2016-0 ,pp. : 142-147

Karger

Access to resources Recommend Favorite

Predictive Factors for Time to Progression after Hyperthermic Mitomycin C Treatment for High-Risk Non-Muscle Invasive Urothelial Carcinoma of the Bladder: An Observational Cohort Study of 97 Patients

By  

Urologia Internationalis, Vol. 96, Iss. 1, 2016-0 ,pp. : 83-90

Karger

Access to resources Recommend Favorite

Metastatic Urothelial Carcinoma of the Prepuce and Glans Penis: Suspected Implantation of Non-Muscle-Invasive Bladder Cancer via Urine

By  

Case Reports in Oncology, Vol. 7, Iss. 2, 2014-07 ,pp. : 509-512

Karger

Access to resources Recommend Favorite